acute lymphoblastic leukaemia/lymphoblastic lymphoma
Categories:
Current SOPs
SOP Numbers | Date of Commencement | Incorporated Material | Status | |
---|---|---|---|---|
Reasonable Hypothesis | ||||
30/05/2022 | Current | Compilation |
SOP Numbers | Date of Commencement | Incorporated Material | Status | |
---|---|---|---|---|
Balance of Probabilities | ||||
05/04/2021 | Current | Principal |
Past Versions of SOPs
SOP Numbers | Date of Commencement | Status | ||
---|---|---|---|---|
Reasonable Hypothesis | Balance of Probabilities | |||
|
30/05/2022 | Current | Amendment | |
05/04/2021 | Current | Principal | ||
previously known as: acute lymphoblastic leukaemia | ||||
18/09/2017 | Revoked | Amendment | ||
18/09/2017 | Revoked | Compilation | ||
|
04/04/2016 | Revoked | Amendment | |
31/10/2012 | Revoked | Principal | ||
previously known as: acute lymphoid leukaemia | ||||
17/10/2001 | Revoked | Principal | ||
01/03/1995 | Revoked | Principal |
Other Information
Subject | Documents | Relevant SOPs | Date | Comment |
---|---|---|---|---|
Reference List | 59/2022 | 12/04/2022 | ||
Amendment Explanatory Statements tabled in Houses of Parliament | 59/2022 | 29/04/2022 | ||
Explanatory Statements tabled in Houses of Parliament | 33/2021 34/2021 | 05/04/2021 |